Morning Briefing
Summaries of health policy coverage from major news organizations
Sanofi-Aventis Begins Work on $477M Dengue Vaccine Plant
Sanofi-Aventis on Tuesday started work on a $477 million plant north of Lyon, France, that will be devoted to the production of a vaccine against dengue fever, AP/Forbes reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
